The BRCA1 suppressor hypothesis: an explanation for the tissue-specific tumor development in BRCA1 patients

Humoral pregnancy analyses reveal strategies for fetal protection and aberrancy in miscarriage.

Cell reports. Medicine·2026

Virome-wide ubiquitin ligase discovery reveals diverse mechanisms of immune evasion.

Science (New York, N.Y.)·2026

A viral ORFeome library for systems-level genetic dissection of host-pathogen interactions.

Cell·2026

Persistence of memory: lifespan dynamics of the human antiviral antibody reactome.

Nature communications·2026

Systems-Scale Structural Modeling Reveals the Germline Architecture of Immunodominance.

bioRxiv : the preprint server for biology·2026

Integrative Molecular Analyses of Inflammatory and Autoimmune Signals in Cardiac Sarcoidosis.

Circulation·2026

Proteo-genomics-guided interpretation of somatic mutations in cancer genomes.

Cancer cell·2026

Tumor cells recruit macrophage bodyguards to outlast chemotherapy.

Cancer cell·2026

Biological aging and the hidden architecture of early-onset cancer risk.

Cancer cell·2026

Intratumoral Bacillus cereus orchestrates stem-like lymphoid niches to potentiate immunotherapy response in hepatocellular carcinoma.

Cancer cell·2026

EGFR-targeting ADCs: From oncogene addiction to antigen-guided drug delivery.

Cancer cell·2026

SYS6010, epidermal growth factor receptor-targeting antibody-drug conjugate for advanced non-small cell lung cancer: A phase 1 trial.

Cancer cell·2026

Identification of a novel small-molecule modulator targeting SNX10 to inhibit osteoclastic bone resorption.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026

Outcomes of target therapies for pediatric BRAF V600-mutant low-grade gliomas: A systematic review and meta-analysis.

Neuro-oncology advances·2026

Research on serine hydroxymethyltransferase 2 mechanisms in malignant tumor development and progression.

PeerJ·2026

Titanium dioxide nanoparticle-modified screen-printed electrode for erlotinib determination.

ADMET & DMPK·2026

Advances in FGF/FGFR Signaling: Implications for Disease and Therapy.

MedComm·2026

Recurrence distance analysis for clinical target volume optimization in glioblastoma.

Clinical and translational radiation oncology·2026

Related Experiment Videos

The BRCA1 suppressor hypothesis: an explanation for the tissue-specific tumor development in BRCA1 patients

Related Concept Videos

Humoral pregnancy analyses reveal strategies for fetal protection and aberrancy in miscarriage.

Virome-wide ubiquitin ligase discovery reveals diverse mechanisms of immune evasion.

A viral ORFeome library for systems-level genetic dissection of host-pathogen interactions.

Persistence of memory: lifespan dynamics of the human antiviral antibody reactome.

Systems-Scale Structural Modeling Reveals the Germline Architecture of Immunodominance.

Integrative Molecular Analyses of Inflammatory and Autoimmune Signals in Cardiac Sarcoidosis.

Proteo-genomics-guided interpretation of somatic mutations in cancer genomes.

Tumor cells recruit macrophage bodyguards to outlast chemotherapy.

Biological aging and the hidden architecture of early-onset cancer risk.

Intratumoral Bacillus cereus orchestrates stem-like lymphoid niches to potentiate immunotherapy response in hepatocellular carcinoma.

EGFR-targeting ADCs: From oncogene addiction to antigen-guided drug delivery.

SYS6010, epidermal growth factor receptor-targeting antibody-drug conjugate for advanced non-small cell lung cancer: A phase 1 trial.

Identification of a novel small-molecule modulator targeting SNX10 to inhibit osteoclastic bone resorption.

Outcomes of target therapies for pediatric BRAF V600-mutant low-grade gliomas: A systematic review and meta-analysis.

Research on serine hydroxymethyltransferase 2 mechanisms in malignant tumor development and progression.

Titanium dioxide nanoparticle-modified screen-printed electrode for erlotinib determination.

Advances in FGF/FGFR Signaling: Implications for Disease and Therapy.

Recurrence distance analysis for clinical target volume optimization in glioblastoma.

Related Experiment Videos

The BRCA1 suppressor hypothesis: an explanation for the tissue-specific tumor development in BRCA1 patients

Related Concept Videos

Related Articles